0,00 €
currency
0

APO-IBUPROFEN Rapid cps 20x 400mg

50066721

Medicinal preparation

APO-IBUPROFEN Rapid cps 20x 400mg
4,00 €
Total including VAT
We regret, but the goods you are looking for are not available at the moment. For more detailed information you can contact us at info@docsimon.cz

Application form: tablets, capsules

Indication group: analgesics, antipyretics
nonsteroid antiphlogistics and antirheumatics

Active substance: Ibuprofenum 400 mg

Pregnancy and lactation: In the first and the second third of pregnancy ibuprofen can be taken only after consultation with your doctor. Ibuprofen should not be taken in the last third of pregnancy due to a higher risk of complications for the mother and her child. Ibuprofen and its metabolites pass in small amounts into breast milk. Since to date the adverse effects after use of ibuprofen are not know, it is not necessary to temporarily interrupt breastfeeding with a short-term administration of the drug. If your treatment is long-term and/or you take high doses, breastfeeding should be interrupted. If ibuprofen is administrated to women who want to become pregnant or to women in the first and the second trimester of pregnancy, the dose must be as low as possible and the length of the treatment as short as possible. Ibuprofen is contraindicated in the third trimester of pregnancy.

minimum amount for dispatch: APO-IBUPROFENUM Rapid cps : The preparation contains the active substance ibuprofen that has an anti-inflammatory effect, relieves pain and decreases temperature.

EAN: 8594158133397

Manufacturer: Apotex Nederland B.V., Leiden, Netherlands, www.apotex.com

Parametry
SUKL názevAPO-IBUPROFEN RAPID 400 MG SOFT CAPSULES 400MG CPS MOL 20 I
SUKL kód0170271

APO-IBUPROFENUM RAPID 400mg por cps mol 20x400mg
Ověření internetových stránek a lékárny:
SUKL
Státní ústav pro kontrolu léčiv, Šrobárova 48, 100 41 Praha 10, www.sukl.cz

Reporting of side effects
© Česká lékárna Holding a.s. All rights reserved.

info  Cookies help us in providing our services. By using our services, you agree to our use of cookies.